Friday, January 27, 2012 4:08:51 PM
Re: What happens ...
Yep, Doc gave you the right answer, but it might be kinda entertaining to ask your broker the same question. Might, um, have to refresh his memory about the term.
Anyway, here's a little, real-life drama involving shares borrowed from an eTrade account. Note the Shrt/Cvr designation in the screen cap. You might have to follow the thread to put it into context.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=65612502&txt2find=etrade|shorts
Yep, Doc gave you the right answer, but it might be kinda entertaining to ask your broker the same question. Might, um, have to refresh his memory about the term.
Anyway, here's a little, real-life drama involving shares borrowed from an eTrade account. Note the Shrt/Cvr designation in the screen cap. You might have to follow the thread to put it into context.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=65612502&txt2find=etrade|shorts
Recent PTIX News
- Protagenic Therapeutics Completes Phytanix Separation, Strengthens Balance Sheet and Repositions the Company Around PT00114 • ACCESS Newswire • 03/17/2026 12:00:00 PM
- Protagenic Therapeutics Upgrades from OTC Pink to OTCQB Venture Market • ACCESS Newswire • 03/10/2026 12:00:00 PM
- Results from Phase 1 Multiple-Dose Study of PT00114 • ACCESS Newswire • 12/09/2025 01:46:00 PM
- Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice • ACCESS Newswire • 11/27/2025 08:45:00 AM
- Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study • ACCESS Newswire • 11/13/2025 01:22:00 PM
- Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates • GlobeNewswire Inc. • 07/30/2025 12:30:00 PM
